459 related articles for article (PubMed ID: 21549790)
1. A DNA vaccine encoding ubiquitinated Rift Valley fever virus nucleoprotein provides consistent immunity and protects IFNAR(-/-) mice upon lethal virus challenge.
Boshra H; Lorenzo G; Rodriguez F; Brun A
Vaccine; 2011 Jun; 29(27):4469-75. PubMed ID: 21549790
[TBL] [Abstract][Full Text] [Related]
2. Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens.
Lorenzo G; Martín-Folgar R; Hevia E; Boshra H; Brun A
Vaccine; 2010 Apr; 28(17):2937-44. PubMed ID: 20188678
[TBL] [Abstract][Full Text] [Related]
3. [Study on DNA immune of envelope protein gene of Rift Valley Fever Virus].
Wang QH; Wang XJ; Hu S; Ge JY; Bu ZG
Wei Sheng Wu Xue Bao; 2007 Aug; 47(4):677-81. PubMed ID: 17944371
[TBL] [Abstract][Full Text] [Related]
4. A single immunization with MVA expressing GnGc glycoproteins promotes epitope-specific CD8+-T cell activation and protects immune-competent mice against a lethal RVFV infection.
López-Gil E; Lorenzo G; Hevia E; Borrego B; Eiden M; Groschup M; Gilbert SC; Brun A
PLoS Negl Trop Dis; 2013; 7(7):e2309. PubMed ID: 23875044
[TBL] [Abstract][Full Text] [Related]
5. Priming with DNA plasmids encoding the nucleocapsid protein and glycoprotein precursors from Rift Valley fever virus accelerates the immune responses induced by an attenuated vaccine in sheep.
Lorenzo G; Martín-Folgar R; Rodríguez F; Brun A
Vaccine; 2008 Sep; 26(41):5255-62. PubMed ID: 18682268
[TBL] [Abstract][Full Text] [Related]
6. An alphavirus replicon-derived candidate vaccine against Rift Valley fever virus.
Heise MT; Whitmore A; Thompson J; Parsons M; Grobbelaar AA; Kemp A; Paweska JT; Madric K; White LJ; Swanepoel R; Burt FJ
Epidemiol Infect; 2009 Sep; 137(9):1309-18. PubMed ID: 19171081
[TBL] [Abstract][Full Text] [Related]
7. Protective immune responses induced by different recombinant vaccine regimes to Rift Valley fever.
Wallace DB; Ellis CE; Espach A; Smith SJ; Greyling RR; Viljoen GJ
Vaccine; 2006 Nov; 24(49-50):7181-9. PubMed ID: 16870311
[TBL] [Abstract][Full Text] [Related]
8. Rift Valley fever virus immunity provided by a paramyxovirus vaccine vector.
Kortekaas J; de Boer SM; Kant J; Vloet RP; Antonis AF; Moormann RJ
Vaccine; 2010 Jun; 28(27):4394-401. PubMed ID: 20434545
[TBL] [Abstract][Full Text] [Related]
9. DNA vaccination regimes against Schmallenberg virus infection in IFNAR
Boshra HY; Charro D; Lorenzo G; Sánchez I; Lazaro B; Brun A; Abrescia NG
Antiviral Res; 2017 May; 141():107-115. PubMed ID: 28235558
[TBL] [Abstract][Full Text] [Related]
10. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
[TBL] [Abstract][Full Text] [Related]
11. Rift Valley fever virus subunit vaccines confer complete protection against a lethal virus challenge.
de Boer SM; Kortekaas J; Antonis AF; Kant J; van Oploo JL; Rottier PJ; Moormann RJ; Bosch BJ
Vaccine; 2010 Mar; 28(11):2330-9. PubMed ID: 20056185
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
13. Plasmid DNA vaccines are effective in the absence of IFNgamma.
Hassett DE; Zhang J; Whitton JL
Virology; 1999 Oct; 263(1):175-83. PubMed ID: 10544092
[TBL] [Abstract][Full Text] [Related]
14. Genetically Modified Rabies Virus Vector-Based Rift Valley Fever Virus Vaccine is Safe and Induces Efficacious Immune Responses in Mice.
Zhang S; Hao M; Feng N; Jin H; Yan F; Chi H; Wang H; Han Q; Wang J; Wong G; Liu B; Wu J; Bi Y; Wang T; Sun W; Gao Y; Yang S; Zhao Y; Xia X
Viruses; 2019 Oct; 11(10):. PubMed ID: 31597372
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of three candidate Rift Valley fever vaccines in sheep.
Kortekaas J; Antonis AF; Kant J; Vloet RP; Vogel A; Oreshkova N; de Boer SM; Bosch BJ; Moormann RJ
Vaccine; 2012 May; 30(23):3423-9. PubMed ID: 22449427
[TBL] [Abstract][Full Text] [Related]
16. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
Morrill JC; Peters CJ
J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
[TBL] [Abstract][Full Text] [Related]
17. Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus.
Bhardwaj N; Heise MT; Ross TM
PLoS Negl Trop Dis; 2010 Jun; 4(6):e725. PubMed ID: 20582312
[TBL] [Abstract][Full Text] [Related]
18. Characterisation of immune responses and protective efficacy in mice after immunisation with Rift Valley Fever virus cDNA constructs.
Lagerqvist N; Näslund J; Lundkvist A; Bouloy M; Ahlm C; Bucht G
Virol J; 2009 Jan; 6():6. PubMed ID: 19149901
[TBL] [Abstract][Full Text] [Related]
19. Protection against Rift Valley fever virus infection in mice upon administration of interferon-inducing RNA transcripts from the FMDV genome.
Lorenzo G; Rodríguez-Pulido M; López-Gil E; Sobrino F; Borrego B; Sáiz M; Brun A
Antiviral Res; 2014 Sep; 109():64-7. PubMed ID: 24973761
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the immunogenicity and protective efficacy of a DNA vaccine encoding Lassa virus nucleoprotein.
Rodriguez-Carreno MP; Nelson MS; Botten J; Smith-Nixon K; Buchmeier MJ; Whitton JL
Virology; 2005 Apr; 335(1):87-98. PubMed ID: 15823608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]